# 61703-161-05 · Methotrexate Sodium Injection · Hospira, Inc., a Pfizer Company — FDA drug shortage duration tracker

For 61703-161-05, generic name is Methotrexate Sodium Injection; manufacturer is Hospira, Inc., a Pfizer Company; status is Current; availability now is Available; initial posting date is 03/13/2023, recorded from its source on 2026-11-04.

- **Package NDC:** 61703-161-05 _(verified: appears in the quote below)_
- **Generic name:** Methotrexate Sodium Injection _(verified: appears in the quote below)_
- **Manufacturer:** Hospira, Inc., a Pfizer Company _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Available _(verified: appears in the quote below)_
- **Initial posting date:** 03/13/2023 _(verified: appears in the quote below)_
- **Last update date:** 10/29/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1332 _(our reading, not quoted from the source)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Oncology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "03/13/2023", "package_ndc": "61703-161-05", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)", "update_type": "Revised", "initial_posting_date": "03/13/2023", "package_ndc": "61703-161-05", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "10/29/2026", "therapeutic_category": [ "Oncology", "Rheumatology" ], "status": "Current", "dosage_form": "Injection"

### Status

> "presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)", "update_type": "Revised", "initial_posting_date": "03/13/2023", "package_ndc": "61703-161-05", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "10/29/2026", "therapeutic_category": [ "Oncology", "Rheumatology" ], "status": "Current", "dosage_form": "Injection"

### Last update date

> "presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)", "update_type": "Revised", "initial_posting_date": "03/13/2023", "package_ndc": "61703-161-05", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "10/29/2026", "therapeutic_category": [ "Oncology", "Rheumatology" ], "status": "Current", "dosage_form": "Injection"

### Dosage form

> "presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)", "update_type": "Revised", "initial_posting_date": "03/13/2023", "package_ndc": "61703-161-05", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "10/29/2026", "therapeutic_category": [ "Oncology", "Rheumatology" ], "status": "Current", "dosage_form": "Injection"

### Therapeutic category

> "presentation": "Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)", "update_type": "Revised", "initial_posting_date": "03/13/2023", "package_ndc": "61703-161-05", "generic_name": "Methotrexate Sodium Injection", "company_name": "Hospira, Inc., a Pfizer Company", "contact_info": "844-646-4398", "availability": "Available", "update_date": "10/29/2026", "therapeutic_category": [ "Oncology", "Rheumatology" ], "status": "Current", "dosage_form": "Injection"

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-11-04. Review by: 2026-11-07.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).